Related references
Note: Only part of the references are listed.IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Marieke L. Kuijjer et al.
BMC CANCER (2013)
Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor
Shamshad J. Sherajee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
Xianke Zeng et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
Giorgio V. Scagliotti et al.
CANCER TREATMENT REVIEWS (2012)
Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
Aung Naing et al.
CLINICAL CANCER RESEARCH (2012)
Proinsulin Binds with High Affinity the Insulin Receptor Isoform A and Predominantly Activates the Mitogenic Pathway
Roberta Malaguarnera et al.
ENDOCRINOLOGY (2012)
The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
Abdoreza Davoodi-Semiromi et al.
PLOS ONE (2012)
Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
Cecile Pierre-Eugene et al.
PLOS ONE (2012)
Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and-2 Are Differentially Expressed in Prostate Cancer
Martin Heni et al.
PLOS ONE (2012)
Agonism and Antagonism at the Insulin Receptor
Louise Knudsen et al.
PLOS ONE (2012)
Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma
Simon Ekman et al.
ACTA ONCOLOGICA (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer
Xiaonan Hou et al.
CANCER RESEARCH (2011)
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
Beate C. Litzenburger et al.
CLINICAL CANCER RESEARCH (2011)
Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
Richard Quek et al.
CLINICAL CANCER RESEARCH (2011)
18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
Eliot T. McKinley et al.
CLINICAL CANCER RESEARCH (2011)
A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
Francesco Atzori et al.
CLINICAL CANCER RESEARCH (2011)
IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer
Carly Jade Dool et al.
ENDOCRINE-RELATED CANCER (2011)
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
Erin R. King et al.
GYNECOLOGIC ONCOLOGY (2011)
Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review
Emine Elif Ozkan
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Altered Expression of Insulin Receptor Isoforms in Breast Cancer
Jiaqi Huang et al.
PLOS ONE (2011)
Initial Testing (Stage 1) of the IGF-1 Receptor Inhibitor BMS-754807 by the Pediatric Preclinical Testing Program
E. Anders Kolb et al.
PEDIATRIC BLOOD & CANCER (2011)
Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Erin R. King et al.
Recent Patents on Anti-Cancer Drug Discovery (2011)
S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats
Ajit Vikram et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
Marzia B. Gariboldi et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one
Upender Velaparthi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
Paul Haluska et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
Fei Huang et al.
CANCER RESEARCH (2010)
The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer Models
Sara A. Flanigan et al.
CLINICAL CANCER RESEARCH (2010)
Development of an Integrated Genomic Classifier for a Novel Agent in Colorectal Cancer: Approach to Individualized Therapy in Early Development
Todd M. Pitts et al.
CLINICAL CANCER RESEARCH (2010)
Insulin Receptor (IR) Pathway Hyperactivity in IGF-IR Null Cells and Suppression of Downstream Growth Signaling Using the Dual IGF-IR/IR Inhibitor, BMS-754807
Joseph E. Dinchuk et al.
ENDOCRINOLOGY (2010)
Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma
Birgit Geoerger et al.
EUROPEAN JOURNAL OF CANCER (2010)
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab(CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos et al.
LANCET ONCOLOGY (2010)
PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
Daniel Hagerstrand et al.
NEURO-ONCOLOGY (2010)
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
H. Zhang et al.
ONCOGENE (2010)
Treatment of biliary tract cancer with NVP-AEW541: Mechanisms of action and resistance
Samuel Wolf et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
Marie-Claude Beauchamp et al.
JOURNAL OF ONCOLOGY (2010)
Development of Inhibitors of the IGF-IR/PI3K/Akt/mTOR Pathway
Mary L. Hixon et al.
REVIEWS ON RECENT CLINICAL TRIALS (2010)
Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001
Philipp Baumann et al.
ANTI-CANCER DRUGS (2009)
Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression
Toru Mukohara et al.
CANCER LETTERS (2009)
Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro
Andrea E. Wahner Hendrickson et al.
CANCER RESEARCH (2009)
Insulin Receptor Isoform A and Insulin-like Growth Factor II as Additional Treatment Targets in Human Osteosarcoma
Sofia Avnet et al.
CANCER RESEARCH (2009)
The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
Fei Huang et al.
CANCER RESEARCH (2009)
Sequencing of Type I Insulin-Like Growth Factor Receptor Inhibition Affects Chemotherapy Response In vitro and In vivo
Xianke Zeng et al.
CLINICAL CANCER RESEARCH (2009)
Development of the Monoclonal Antibody Figitumumab, Targeting the Insulin-like Growth Factor-1 Receptor, for the Treatment of Patients with Non-Small-Cell Lung Cancer
Antonio Gualberto et al.
CLINICAL LUNG CANCER (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
Marie-Claude Beauchamp et al.
GYNECOLOGIC ONCOLOGY (2009)
Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma
Ferdous M. Barlaskar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Discovery of a 2,4-Disubstituted Pyrrolo[1,2-f][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development
Mark D. Wittman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Madeleine Hewish et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
Insulin Receptor Expression by Human Prostate Cancers
Michael E. Cox et al.
PROSTATE (2009)
A novel high-affinity peptide antagonist to the insulin receptor
Lauge Schaffer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer
Christophe Blanquart et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
Sergey M. Deyev et al.
BIOESSAYS (2008)
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells
Patricia Maiso et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
Christian Moser et al.
EUROPEAN JOURNAL OF CANCER (2008)
Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
Quanri Jin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Association of Hypertension, Diabetes, Dyslipidemia, and Metabolic Syndrome with Obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004
Ninh T. Nguyen et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
Jordi Rodon et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the Pediatric Preclinical Testing Program
E. Anders Kolb et al.
PEDIATRIC BLOOD & CANCER (2008)
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
Chi Tarn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways
Haim Werner et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Mechanisms of disease: signaling of the insulin-like growth factor I receptor pathway-therapeutic perspectives in cancer
Yungan Tao et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
IMC-A12, a human IgG, monoclonal antibody to the insulin-like growth factor I receptor
Eric K. Rowinsky et al.
CLINICAL CANCER RESEARCH (2007)
Preclinical in vivo study of new insulin-like growth factor-1 receptor -: Specific inhibitor in Ewing's sarcoma
Maria C. Manara et al.
CLINICAL CANCER RESEARCH (2007)
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts
P. L. Tazzari et al.
LEUKEMIA (2007)
The insulin-like growth factor 1 receptor in cancer: Old focus, new future
Hermien Hartog et al.
EUROPEAN JOURNAL OF CANCER (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo
Barbara Tanno et al.
CLINICAL CANCER RESEARCH (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors
Jennifer D. Wu et al.
CLINICAL CANCER RESEARCH (2006)
Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates Herceptin activity in vivo
Lori Jerome et al.
CANCER RESEARCH (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Insulin-like growth factor (IGF) family and prostate cancer
C. Gennigens et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
The insulin-like growth factor-1 receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
A Girnita et al.
CLINICAL CANCER RESEARCH (2006)
Insulin-like growth factor receptor I targeting in epithelial ovarian cancer
WH Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2006)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model
E Menu et al.
BLOOD (2006)
Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor
Ana S. Martins et al.
CLINICAL CANCER RESEARCH (2006)
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417
P Haluska et al.
CANCER RESEARCH (2006)
Discovery of a 1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
M Wittman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody
Y Wang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Blocking insulin-like growth factor-I receptor as a strategy for targeting cancer
F Hofmann et al.
DRUG DISCOVERY TODAY (2005)
Molecular interactions of the IGF system
A Denley et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma
K Scotlandi et al.
EUROPEAN JOURNAL OF CANCER (2005)
Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions
CM Duan et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2005)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers
S Miyamoto et al.
CLINICAL CANCER RESEARCH (2005)
In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors
JD Wu et al.
CLINICAL CANCER RESEARCH (2005)
Significant expression of IGFBP2 in breast cancer compared with benign lesions
LT Busund et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Recombinant bispecific antibodies for cancer therapy
RE Kontermann
ACTA PHARMACOLOGICA SINICA (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
In vivo antitumor activity of NVP-AEW541 -: A novel, potent, and selective inhibitor of the IGF-IR kinase
C García-Echeverría et al.
CANCER CELL (2004)
Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR
A Denley et al.
MOLECULAR ENDOCRINOLOGY (2004)
Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors
M Goya et al.
CANCER RESEARCH (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
The therapeutic potential of agents targeting the type I insulin-like growth factor receptor
H Zhang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
Diabetes mellitus and risk of prostate cancer: a meta-analysis
S Bonovas et al.
DIABETOLOGIA (2004)
Adiponectin as a biomarker of the metabolic syndrome
M Ryo et al.
CIRCULATION JOURNAL (2004)
Di-diabody: a novel tetravalent bispecific antibody molecule by design
D Lu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold
L Kissau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks
L Schäffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
G Pandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural biology of insulin and IGF1 receptors: Implications for drug design
P De Meyts et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Insulin-like growth factors and prostate cancer
B Djavan et al.
WORLD JOURNAL OF UROLOGY (2001)
The IGF system in thyroid cancer: new concepts
V Vella et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Diabetes: Risk factor for the development of pancreatic cancer or manifestation of the disease?
WE Fisher
WORLD JOURNAL OF SURGERY (2001)
Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction
J Dupont et al.
HORMONE RESEARCH (2001)
Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
SL Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Share Paper
